Glenmark strengthens on launching nicotine replacement therapy product ‘Kwitz’

17 Nov 2017 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 586.10, up by 5.40 points or 0.93% from its previous closing of Rs. 580.70 on the BSE.

The scrip opened at Rs. 583.55 and has touched a high and low of Rs. 593.00 and Rs. 583.55 respectively. So far 19,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 973.10 on 07-Feb-2017 and a 52 week low of Rs. 565.00 on 16-Nov-2017.

Last one week high and low of the scrip stood at Rs. 593.00 and Rs. 565.00 respectively. The current market cap of the company is Rs. 16,537.00 crore.

The promoters holding in the company stood at 46.53%, while Institutions and Non-Institutions held 38.56% and 14.92% respectively.

Glenmark Pharmaceuticals has launched nicotine replacement therapy product ‘Kwitz’ that helps smokers quit smoking. Kwitz nicotine gum will be available in two variants of 2 mg as an OTC product and 4mg as prescription product. While Kwitz 2 mg is for those smoking less than 20 cigarettes per day, Kwitz 4 mg is meant for smokers consuming more than 20 cigarettes per day.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Glenmark Pharma Share Price

1919.05 -46.70 (-2.38%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×